Preliminary Scientific Program

17th INTERNATIONAL WAA & 3rd HRDS JOINT CONGRESS – ISTANBUL 2020

FRIDAY, APRIL 17th, 2020

08:30-09:30

  • WAA BOARD OF DIRECTORS MEETING (by invitation only)
  • NEW MEMBER AND FIRST TIME ATTENDEE MEET AND GREET

09:30-10:00 – OPENING CEREMONY

  • WELCOME FROM THE PRESIDENT
  • WELCOME FROM THE CONFERENCE CHAIR
  • SCIENTIFIC SYMPOSIUM SPEAKERS will be announced soon…

10:00-12:15 – SCIENTIFIC SESSION: CAR-T CELL

10:00-11:00 –  CAR-T CELL TECHNOLOGY

Chairs: will be announced soon…
Speakers: will be announced soon…

10:00-10:20 – Current status of CAR-T cell technologies

10:20-10:40 – Leukopheresis for CAR T-Cell Therapy: Mononuclear cell collection for engineered T-cells

10-40-11:00 – Processing, quality control and shipment of collected cells and manufacturing

11:00-11:15 –  Coffee break

11:15-12:15 – CAR-T CELL & CLINICAL APPLICATIONS

Chairs: will be announced soon…
Speakers: will be announced soon…

11:15-11:35 – Real life experience in the treatment of ALL patients using commercially available CAR T cells

11:35-11:55 – Identifying the appropriate R/R DLBCL patient for CAR T cell therapy

11:55-12:15 – When to use CAR-T cells in Myeloma patients?

12:15-13:00 –  Lunch Box 

EDUCATION SYMPOSIUM SPEAKERS

  • Dr. Gail RockDr.
  • Vicencio Juárez Barreto
  • Dr. William Clark
  • Dr. Joseph Schwartz
  • Dr. Hans Vrielink
  • Dr. Guiqiang Wang
  • Dr. Robert Weinstein
  • Dr. Joachim Jankowski
  • Dr. Miguel Lozano
  • Dr. Christos Papadimitriou
  • Dr. Angelina Mirasol
  • Dr. Rakesh Srivastava
  • Dr. Yossi Schwartz
  • Dr. Kyou-Sup Han
  • Dr. Rainer Moog
  • Dr. Maria Luisa D. Concepcion
  • Dr. Alfredo Mendrone Jr.
  • Dr. Oliver Hequet
  • Dr. Patrizia Accorsi
  • Dr. Dima Tadeu Covas
  • Dr. Bruce Sachais
  • Dr. Thomas Groth
  • Dr. Wladimir Szpirt
  • Dr. Farhad Heshmati
  • Dr. Ravi Sarode

13:00-14:00  EDUCATION SESSION-I: APHERESIS & TRANSPLANTATION

Chairs: will be announced soon
Speakers: will be announced soon

13:00-13:20 – Apheresis in Liver Transplantation & Liver Failure

13:20-13:40 – Role of ECP in Lung and Cardiac Transplantation

13:40-14:00 – What is the role of apheresis technology in stem cell transplantation?

14:00-14:15 – Coffee break

14:15-15:15 – EDUCATION SESSION-II: CHALLENGING ISSUES IN APHERESIS USE-I

Chairs: will be announced soon
Speakers: will be announced soon

14:15-14:35 – Red Cell Exchange Therapy for Sickle Cell Disease: Albumin Prime vs. Red Cell Prime

14:35-14:55 – Immunoadsorbsion and double filtration in clinical use: Why? When? Who?

14:55-15:15 – Lipoprotein apheresis: is it an optimal therapeutic option to reduce increased Lp(a) levels?

15:15-15:30 – Coffee break

15:30-16:50 – EDUCATION SESSION-III: DIFFERENT TOPICS IN APHERESIS

Chairs: will be announced soon
Speakers: will be announced soon

15:30-15:50 – Hemostasis Management Associated with Therapeutic Plasma Exchange

15:50-16:10 – Photopheresis in clinical use: How? When? Who?

16:10-16:30 – Performing Plasmapheresis on a Newborn

16:30-16:50 – Iron Deficiency in Apheresis Donors: RBC donors? Platelet donors? Plasma donors?

SATURDAY, APRIL 18th, 2020

07:30-08:30 – BREAKFAST WITH THE EXPERTS (Roundtable discussions)

08:30-09:30  – EDUCATION SESSION-IV: MANAGEMENT OF AN APHERESIS SESSION

Chairs: will be announced soon
Speakers: will be announced soon

08:30-08:50 – Influence of vascular access upon efficiency of therapeutic plasma exchange: Peripheral vein, central venous catheter, arterio-venous fistula, or  implantable ports

08:50-09:10 – Anticoagulation Management in Therapeutic Plasma Exchange

09:10-09:30 – Replacement fluids in apheresis: what have changed?

09:30-09:50 –  Coffee break

09:50 -10:00 – EDUCATION SESSION-V: APHERESIS IN DIFFERENT DISCIPLINES

Chairs: will be announced soon
Speakers: will be announced soon

10:00-10:20 – Advancing Apheresis in Neurology: Neurological Disease Indications for Plasma Exchange

10:20-10:40 – The treatment of ANCA-associated rapidly-progressive glomerulonephritis, Goodpasture syndrome, and antibody-mediated rejection in kidney transplantation with therapeutic apheresis

10:40-11:00 – Management of hypertriglyceridemia induced acute pancreatitis

11:00-11:15 – Coffee break

11:15-12:15 – EDUCATION SESSION-VI: CYTAPHERESIS

Chairs: will be announced soon
Speakers: will be announced soon

11:15-11:35 – Therapeutic erythroapheresis: Experience in patients with polycythemia vera and secondary erythrocytosis

11:35-11:55 – Characterization and indications of buffy coat-derived granulocytes for clinical use

11:55-12:15 – Plateletpheresis in Healthy Donors: Clinical considerations

12:15-13:00 – Lunch box

13:00-14:00 – EDUCATION SESSION-VII: APHERESIS IN THE FUTURE

Chairs: will be announced soon
Speakers: will be announced soon

13:00-13:20 – The role of plasma exchange in the management of autoimmune disorders

13:20-13:40 – Current and future treatment options for Thrombotic Thrombocytopenic Purpura

13:40-14:00 – Development of apheresis techniques and equipment designed for pediatric patients

14:00-14:15 – Coffee break

14:15-15:35 – EDUCATION SESSION-VIII: CHALLENGING ISSUES IN APHERESIS USE-II

Chairs: will be announced soon
Speakers: will be announced soon

14:15-14:35 – Adverse events in apheresis: How to manage them?

14:35-14:55 – Apheresis principles during pregnancy: are there challenges?

14:55-15:15 – Apheresis on advanced aged patients/donors with comorbidities

15:15-15:35 – Treatment of cryoglobulinemia with apheresis: How? When: Who?

SUNDAY, APRIL 19th, 2020

09:00-10:00 – POST-CONFERENCE ASFA BOARD OF DIRECTORS MEETING

10:00-12:00 – BOARD OF WAA/HRDS DIRECTORS AND SPONSORS MEETING

12:00-13:00 – CLOSING CEREMONY AND AWARDS